The COVID Pandemic and the New Normal.
COVID-19 has changed the world as we have all known it. This invisible enemy has shut down the economy and our communities.
Recognizing the need to create a comprehensive testing and monitoring program, Inspire Diagnostics has partnered with Heal 360 & Get Home Testing to bring the convenience of testing for COVID-19 without leaving your home to Texas Residents, Local Businesses, and Academic Institution with NO OUT-OF-POCKET COST*.
Our goal is to keep you healthy and help with the transition back to normal life.
*Inspire Diagnostics works with your health plan, the government, a government health plan or the uninsured fund for the testing. There will be no patient out-of-pocket cost.
How does it work?
The average time to deliver results is currently 1-2 days from when your sample is received at the lab. Our labs process samples seven days a week. Check with your local FedEx for pick up and drop off schedules.
1. Select a Billing Option
We can bill your insurance with no out-of-cost to you or utilize federal funds if you are uninsured.
2. Receive your sample collection kit
COVID-19 kits are sent via UPS. Most kits will be delivered within 2 days.
3. Speak with our medical provider over Zoom and collect your sample
Our medical providers are available to screen your symptoms and provide you a plan of care.
4. Send back to our lab for processing & access your results online
Securely access results via text/email. A clinician consult is available to users with positive or indeterminate test results.
Why Testing is Important
COVID-19 is a virus that is very infectious between 3 to 10 days from the time of infection
Over 40% of the people who have the virus are asymptomatic and show no symptoms
Without testing, there is not a clear way to monitor against the infection
Frequent testing has been shown to be the best way to create a safer environment
Our team has designed a high quality COVID-19 testing program, utilizing EUA authorized tests to identify both symptomatic and asymptomatic individuals with COVID-19.